Mechanism of dual specificity kinase activity of DYRK1A

Agnes Walte1, Katharina Rüben, Ruth Birner-Gruenberger

  • 1Institute of Pharmacology and Toxicology, RWTH Aachen University, Germany.

The FEBS Journal
|July 2, 2013
PubMed

Insights

Dual Specificity Tyrosine-Phosphorylation-Regulated Kinases (DYRKs) use tyrosine autophosphorylation to enhance their serine/threonine kinase activity. This process stabilizes the catalytic domain, enabling dual specificity without losing tyrosine phosphorylation.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Enzymology

Background:

  • Protein kinase function is often regulated by tyrosine phosphorylation in the activation loop.
  • Dual specificity tyrosine-phosphorylation-regulated kinases (DYRKs) exhibit unique substrate phosphorylation on aliphatic amino acids, contrasting with their tyrosine autophosphorylation.

Purpose of the Study:

  • To elucidate the mechanism underlying the dual specificity kinase activity in DYRK1A and related kinases.
  • To investigate the role of tyrosine autophosphorylation in DYRK1A maturation and activity.

Main Methods:

  • In vitro translation and expression in bacterial and mammalian systems to study DYRK1A tyrosine autophosphorylation.
  • Analysis of point mutants lacking the activation loop tyrosine to assess tyrosine kinase activity.
  • Pharmacological inhibition using diverse DYRK1A inhibitors to probe catalytic domain conformations.
  • In vitro and in vivo studies on related cyclin-dependent kinase-like kinases (CLKs).

Main Results:

  • DYRK1A tyrosine autophosphorylation occurs rapidly during in vitro translation and in mature forms, independent of non-catalytic domains or other proteins.
  • Mutants lacking the activation loop tyrosine displayed increased tyrosine kinase activity.
  • DYRK1A inhibitors showed higher potency against substrate phosphorylation than autophosphorylation, but did not differentially inhibit threonine versus tyrosine activity.
  • CLKs, lacking the activation loop tyrosine, also exhibited tyrosine autophosphorylation.

Conclusions:

  • A model of DYRK autoactivation is proposed, where tyrosine autophosphorylation in the activation loop stabilizes a catalytically active conformation.
  • This stabilization enhances serine/threonine kinase activity while retaining tyrosine phosphorylation capability.
  • The elucidated mechanism likely extends to other serine/threonine kinases reliant on tyrosine autophosphorylation for maturation.

Related Concept Videos

Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...